BioMedha

BioMedha is a UK-based pre-clinical CRO providing in vitro biology expertise to the global drug discovery industry. We are industry-experienced, in vitro biology-focused scientists and can add significant value to our client programmes by undertaking key elements of the early stage drug discovery process. BioMedha expertise includes: • HTA authorized establishment with on-site blood donor panel • Immunology, Oncology, Immuno-oncology, and inflammation studies • Target validation, assay development, screening, and MOA studies • Whole blood and Immune cell functional assays • Flow cytometry capabilities • Cytokine assays and Luminex multiplexing • Cell imaging expertise • Expression studies (protein levels, mRNA levels, and surface expression) • Plate reader-based assays (Fluorescence, Luminesce, Absorbance, FP, FRET, BRET, Alphascreen, HTRF) • Functional assays (e.g. signalling pathways, bioassays) • GPCRs: assay development and screening • Protein-Protein Interactions (PPI) • Enzyme activity • Discovery Toxicology studies We are a small but passionate team of scientists with substantial experience in the pharmaceutical and biotech industries, focused heavily on pre-clinical drug discovery biology. We serve clients in pharma, biotech, virtual companies, spin-outs, and academic institutions.